Article and Video CATEGORIES
ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC by Dr. David Gerber
Dr. David Gerber, University of Texas-Southwestern, reviews results from RTOG 0617 that help clarify the optimal dose of radiation for stage III unresectable NSCLC.
[powerpress]
ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC Audio Podcast
Please feel free to offer comments and raise questions in our
discussion forums.